Published in Br Med J on July 03, 1976
Prostaglandin synthesis and renal function in man. J Physiol (1980) 0.88
Estimation of glomerular filtration rate from the serum creatinine concentration. Postgrad Med J (1988) 0.84
The effect of salsalate therapy on endothelial function in a broad range of subjects. J Am Heart Assoc (2014) 0.79
The effect of acyclovir on the tubular secretion of creatinine in vitro. J Transl Med (2010) 0.77
Acetylsalicylic acid and renal function. Br Med J (1980) 0.75
Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate. World J Methodol (2017) 0.75
Renal abnormalities in rheumatoid arthritis. Ann Rheum Dis (1968) 2.42
Measurement of glomerular filtration-rate in man using a 51Cr-edetic-acid complex. Lancet (1967) 2.05
Chromium-51 ethylenediaminetetraacetate for estimation of globerular filtration rate. Science (1966) 1.29
Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12
Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med (2000) 5.58
Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum (1995) 5.32
Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis (1992) 4.79
Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum (2000) 4.52
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37
Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report. Ann Rheum Dis (1974) 3.77
Apatite deposition disease. A new arthropathy. Lancet (1976) 3.53
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis (2008) 3.52
Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis (1993) 3.16
Knee pain and disability in the community. Br J Rheumatol (1992) 3.15
Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet (1976) 3.07
Another look at osteoarthritis. Ann Rheum Dis (1979) 3.06
Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum (1995) 3.05
The need to make rugby safer. Br Med J (Clin Res Ed) (1988) 2.77
Radiographic assessment of the knee joint in osteoarthritis. Ann Rheum Dis (1992) 2.75
The importance of iron in rheumatoid disease. Lancet (1981) 2.44
Accident compensation: gates and gatekeepers. Med J Aust (1990) 2.42
Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis (1990) 2.04
Vasculitis with alclofenac therapy. Br Med J (1974) 2.02
Observations on the effect of immersion in Bath spa water. Br Med J (Clin Res Ed) (1986) 1.94
Cervical injury in rugby football--a New Zealand survey. Br J Sports Med (1981) 1.92
Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis (2006) 1.89
Intra-articular steroids in osteoarthritis. Rheumatol Rehabil (1980) 1.85
Synovial fluid crystals. Q J Med (1979) 1.77
An articular index for the assessment of osteoarthritis. Ann Rheum Dis (1981) 1.70
Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol (1995) 1.61
Apatite associated destructive arthritis. Br J Rheumatol (1984) 1.61
Extradural corticosteroid injection in management of lumbar nerve root compression. Br Med J (1973) 1.56
Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med (1989) 1.55
The identification of particulate matter in biological tissues and fluids. J Pathol (1977) 1.54
Effect of a specific iron chelating agent on animal models of inflammation. Ann Rheum Dis (1983) 1.52
Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis (2000) 1.52
Pyrophosphate arthropathy: a study of metabolic associations and laboratory data. Ann Rheum Dis (1982) 1.50
Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies. Ann Rheum Dis (1987) 1.49
Serum and synovial fluid osteocalcin (bone gla protein) levels in joint disease. Br J Rheumatol (1989) 1.48
Continuous and intermittent levamisole. A controlled trial. Ann Rheum Dis (1978) 1.45
99mTc HMDP bone scanning in generalised nodal osteoarthritis. II. The four hour bone scan image predicts radiographic change. Ann Rheum Dis (1986) 1.43
Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis (1987) 1.43
Structural periodicity in human articular cartilage: comparison between magnetic resonance imaging and histological findings. Osteoarthritis Cartilage (1999) 1.41
Brown's syndrome: an unusual ocular complication of rheumatoid arthritis. Ann Rheum Dis (1990) 1.41
Wear of articular cartilage: the effect of crystals. Proc Inst Mech Eng H (1993) 1.40
Unmet need for joint replacement: a qualitative investigation of barriers to treatment among individuals with severe pain and disability of the hip and knee. Rheumatology (Oxford) (2003) 1.40
Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity. Ann Rheum Dis (1983) 1.39
Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint. Ann Rheum Dis (2000) 1.39
Mixed crystal deposition disease and osteoarthritis. Br Med J (1978) 1.39
Is progressive osteoarthritis an atheromatous vascular disease? Ann Rheum Dis (2005) 1.38
Pertussis vaccine pleurisy: a model of delayed hypersensitivity. Agents Actions (1976) 1.37
Subarachnoid haemorrhage. A follow-up study of 109 cases admitted during a five year period. N Z Med J (1966) 1.36
Clinical effectiveness of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain: a cluster randomized trial. Arthritis Rheum (2007) 1.34
Identification of pathological mineral deposits by Raman microscopy. Lancet (1991) 1.32
Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis. Ann Rheum Dis (1981) 1.30
Diurnal variation in the femoral articular cartilage of the knee in young adult humans. Magn Reson Med (2000) 1.28
Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest (1994) 1.27
The treatment of gout with azapropazone: clinical and experimental studies. Eur J Rheumatol Inflamm (1981) 1.26
The use of beta-N-acetylglucosaminidase excretion to investigate renal disease in rheumatoid arthritis. Rheumatol Rehabil (1975) 1.25
Magnetic resonance imaging in osteoarthritis of the knee: correlation with radiographic and scintigraphic findings. Ann Rheum Dis (1991) 1.24
Treatment of vasospastic disease with prostaglandin E1. Br Med J (1980) 1.23
Outcomes of total knee replacement: a qualitative study. Rheumatology (Oxford) (2005) 1.23
Ibuprofen in the management of osteoarthrosis of the hip. Rheumatol Phys Med (1972) 1.22
D-penicillamine and immune complex deposition. Ann Rheum Dis (1979) 1.20
Effect of alignment of the medial tibial plateau and x-ray beam on apparent progression of osteoarthritis in the standing anteroposterior knee radiograph. Arthritis Rheum (2001) 1.19
Pulmonary and pleural lesions in rheumatoid disease. Br J Dis Chest (1978) 1.18
Pertussis vaccine oedema: an experimental model for the action of penicillamine-like drugs. Agents Actions (1976) 1.17
Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2). Br J Dermatol (1982) 1.17
No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging. Osteoarthritis Cartilage (2002) 1.17
Localised chondrocalcinosis in post-meniscectomy knees. Lancet (1982) 1.17
Effect of intra-articular corticosteroid injections on primate cartilage. Ann Rheum Dis (1977) 1.14
Enhanced oxidative response of polymorphonuclear leukocytes from synovial fluids of patients with rheumatoid arthritis. Autoimmunity (1988) 1.13
The role of particles in the pathogenesis of joint disease. Curr Top Pathol (1982) 1.13
Renal damage during treatment with antirheumatic drugs. Br Med J (1978) 1.13
Who should have priority for a knee joint replacement? Rheumatology (Oxford) (2002) 1.12
The response of synovial fluid lymphocytes to T and B stimulants in vitro. Immunology (1973) 1.11
Outcome of conservative and surgical management of navicular stress fracture in athletes. Eighty-six cases proven with computerized tomography. Am J Sports Med (1993) 1.10
Low back injury in sport. Rheumatol Rehabil (1977) 1.10
Economic evaluation of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain. Arthritis Rheum (2007) 1.09
Elevated serum C-reactive protein levels in osteoarthritis. Br J Rheumatol (1997) 1.08
Diuretic-induced gout in elderly women. Br J Rheumatol (1985) 1.07
Care of sports injuries in New Zealand--who pays? N Z Med J (1986) 1.06
Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles. Ann Rheum Dis (1983) 1.05
Absence of prostaglandin stimulated increase in acute phase proteins in systemic sclerosis. Lancet (1980) 1.04
Acute pseudogout: "crystal shedding" or acute crystallization? Arthritis Rheum (1981) 1.04
Human cartilage is degraded by rheumatoid arthritis synovial fluid but not by recombinant cytokines in vitro. Clin Exp Immunol (1991) 1.03
Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum (1991) 1.03
Salicylates and renal function in rheumatoid arthritis. Br Med J (1976) 1.03
Lateral subluxation of the atlanto-axial joint in rheumatoid arthritis. Ann Rheum Dis (1978) 1.03
Comparison of aspirin and benorylate in the treatment of rheumatoid arthritis. Br Med J (1972) 1.02
Anticonvulsant intoxication precipitated by azapropazone. Postgrad Med J (1981) 1.02
Pyrophosphate arthropathy: a clinical and radiological study of 105 cases. Ann Rheum Dis (1982) 1.01
99mTc HMDP bone scanning in generalised nodal osteoarthritis. I. Comparison of the standard radiograph and four hour bone scan image of the hand. Ann Rheum Dis (1986) 1.01
Reduced glomerular function in rheumatoid arthritis. Ann Rheum Dis (1972) 1.01
Inflammatory responses to intradermal crystals in healthy volunteers and patients with rheumatic diseases. Rheumatol Int (1982) 1.01
Orudis in management of rheumatoid arthritis and osteoarthrosis of the hip: comparison with indomethacin. Br Med J (1972) 1.00
Survival of calcium pyrophosphate crystals in stored synovial fluids. Ann Rheum Dis (1991) 0.99
Idiopathic haemorrhagic rupture of the shoulder in destructive disease of the elderly. Ann Rheum Dis (1986) 0.99
Depression in rheumatoid disease. Ann Rheum Dis (1974) 0.98
Pre-operative expectation predicts 12-month post-operative outcome among patients undergoing primary total hip replacement in European orthopaedic centres. Osteoarthritis Cartilage (2011) 0.98